Center of Excellence for Precision Medicine

Welcome to the Center of Excellence for Precision Medicine (CEPM) at the University of Sharjah.

Established on May 5, 2023, CEPM is dedicated to advancing scientific discovery and transforming innovative research into meaningful improvements in human health. Our vision is to contribute to the future of precision medicine by integrating cutting-edge molecular technologies, computational sciences, and artificial intelligence to better understand diseases and develop personalized approaches to diagnosis, prevention, and treatment.

At CEPM, we bring together a multidisciplinary team of researchers with expertise spanning genomics, transcriptomics, proteomics, metabolomics, bioinformatics, molecular biology, drug development, and computational medicine. Our research focuses on addressing complex health challenges, including cancer, genetic and rare disorders, neurological diseases, and other conditions. Through advanced multi-omics technologies, single-cell analysis, structural bioinformatics, and artificial intelligence, we aim to uncover disease mechanisms, identify novel biomarkers and therapeutic targets, and advance innovative diagnostic and treatment strategies.

Collaboration is central to our mission. We are committed to strengthening partnerships with academic institutions, healthcare providers, research centers, and industry partners locally and internationally. These collaborations promote knowledge exchange, accelerate translational research, and create opportunities to transform scientific discoveries into practical healthcare solutions.

Equally important is our commitment to nurturing the next generation of scientists. Through interdisciplinary training, mentorship, and access to advanced research technologies, we strive to empower students and early-career researchers with the knowledge and skills needed to contribute to the rapidly evolving field of precision medicine.

As we continue to grow, our ambition is to establish CEPM as a leading center for scientific innovation, interdisciplinary collaboration, and translational research, contributing to the advancement of precision healthcare in the UAE and beyond.

I warmly welcome researchers, students, clinicians, and collaborators to explore our work, engage with our scientific community, and join us in shaping a future where medical care is increasingly precise, personalized, and effective.

Researchers of CEPM works in an integrative and multi-disciplinary setting to uncover many questions revolving around the causes, patterns, and treatment responses associated with various diseases including cancer, diabetes, asthma among others. They employ AI to define and understand the functions of gene products involved in various diseases. Ultimately, translate the research findings into diagnosis and treatment. Finally, the center investigators utilize state-of-the-art approaches in all phases of their work to develop AI-based innovations in all fields of human health and biology. Additionally, the investigators contribute to technology development in computational genomics of both human and microorganisms.

1. Personalized Medical Approaches. To tailor medical decisions, treatments, and interventions based on individual patient characteristics including genetic, environmental, and lifestyle factors through the integration of clinical, laboratory, bioinformatics, and artificial intelligence approaches.

2. Cancer Genomics and Resistance Mechanisms. To investigate critical regions of the human genome to understand their role in cancer initiation, progression, and resistance to treatment, contributing to innovative and impactful cancer research.

3. Strategic Collaborations and Biobanking. To establish and strengthen partnerships with national and international institutions, medical centres, and healthcare providers, while maintaining a comprehensive biobank of normal and diseased tissues for translational research.

4. Multiomics Integration and Biomarker Discovery. To integrate genomics, transcriptomics, proteomics, and other ‘omics technologies with existing platforms to accelerate the discovery and validation of novel diagnostic and prognostic biomarkers for a range of diseases.

5. Single-Cell and Multiomics Technology Development. To develop and apply advanced single-cell and multi-omic techniques that enable precise investigation of disease mechanisms at cellular resolution.

6. Epigenetics and Health Impact Studies. To design and implement innovative methods to identify epigenetic variations and study their impact on human health and disease outcomes.

7. Innovations in Microbiology for Market Applications. To develop novel microbiological techniques and platforms with potential for commercialization and public health advancement.

8. Translation of Research into Public Benefit. To ensure the effective translation of scientific discoveries into innovative diagnostic tools, therapeutic strategies, and public health solutions.

9. Capacity Building and Training. To build research capacity by training students and researchers in advanced scientific techniques and processes aligned with CEPM’s mission, enhancing local and regional expertise.

10. Integrative and Multidisciplinary Research. To foster a collaborative, multidisciplinary research environment aimed at uncovering the underlying causes, patterns, and treatment responses associated with complex diseases.

11. Identification of Novel Molecular Targets. To identify new molecular targets for the diagnosis, monitoring, and treatment of various diseases through systematic and high-throughput investigation.

12. Innovation in Diagnostics and Therapeutics. To translate cutting-edge research findings into innovative diagnostic tools and targeted treatment approaches that address unmet clinical needs.

13. Artificial Intelligence and OMICS Interpretation. To leverage artificial intelligence and machine learning for the integration and interpretation of multiomics data, facilitating the development of next-generation diagnostic and therapeutic technologies.

14. Computational Genomics and Technology Development. To advance technology development in computational genomics, structural bioinformatics, and systems biology for deeper insights into disease mechanisms and precision interventions.

• Precision medicine using integrated clinical, lab, bioinformatics, and omics data
• Cancer genomics and treatment resistance mechanisms
• National/international collaborations and biobanking for translational research
• Multiomics integration for biomarker discovery and validation
• Single-cell and advanced omics technologies for disease mechanisms
• Epigenetics and its impact on health and disease outcomes
• Translational research into diagnostics, therapeutics, and public health solutions
• Innovation in microbiology with commercialization potential
• Identification of novel molecular targets for diagnosis and therapy
• AI-enabled interpretation of omics and computational genomics
• Multidisciplinary, integrative research environment
• Capacity building and advanced training for researchers and students